Abstract: A biocarrier loaded with up to 60% by weight of a mixture including a biological control agent. The biocarrier is derived from the residual cell mass remaining after lipids and soluble proteins and sugars have at least in part been removed from crushed or ground oil seeds. The biological control agent is an agrochemical, biopesticide or mixtures thereof. When the product is formulated as a granule, tablet or briquette it has good hardness and produces substantially no dust, thereby reducing operator exposure to the biological control agent.

Abstract: The present invention relates to somatic mutations in the Multiple Tumor Suppressor (MTS) gene in human cancers and their use in the diagnosis and prognosis of human cancer. The invention further relates to germ line mutations in the MTS gene and their use in the diagnosis of predisposition to melanoma, leukemia, astrocytoma, glioblastoma, lymphoma, glioma, Hodgkin's lymphoma, CLL, and cancers of the pancreas, breast, thyroid, ovary, uterus, testis, kidney, stomach and rectum. The invention also relates to the therapy of human cancers which have a mutation in the MTS gene, including gene therapy, protein replacement therapy and protein mimetics. Finally, the invention relates to the screening of drugs for cancer therapy.